Youhong Hu

904 total citations
39 papers, 772 citations indexed

About

Youhong Hu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Youhong Hu has authored 39 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Youhong Hu's work include Liver physiology and pathology (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Youhong Hu is often cited by papers focused on Liver physiology and pathology (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Youhong Hu collaborates with scholars based in China, United States and Czechia. Youhong Hu's co-authors include Xin Li, Fuchun Xie, Yongzhou Hu, Rongrong Tao, Feng Han, Lingjuan Hong, Juan Cheng, Ying‐Mei Lu, Quan Jiang and Nannan Lu and has published in prestigious journals such as Journal of the American Chemical Society, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Youhong Hu

36 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youhong Hu China 16 262 203 158 125 107 39 772
Yuyan Li China 18 294 1.1× 122 0.6× 133 0.8× 315 2.5× 107 1.0× 51 1.0k
Kondapa Naidu Bobba India 17 176 0.7× 165 0.8× 223 1.4× 50 0.4× 192 1.8× 32 721
Ruijuan Liu China 17 684 2.6× 279 1.4× 115 0.7× 35 0.3× 126 1.2× 35 1.2k
Maria Weber United Kingdom 11 156 0.6× 93 0.5× 273 1.7× 123 1.0× 173 1.6× 18 610
Xuepeng Dong China 11 281 1.1× 97 0.5× 120 0.8× 38 0.3× 133 1.2× 23 535
Jin Young Kim South Korea 15 363 1.4× 64 0.3× 240 1.5× 42 0.3× 145 1.4× 43 876
Pat R. R. Langridge‐Smith United Kingdom 16 485 1.9× 76 0.4× 203 1.3× 64 0.5× 41 0.4× 25 853
Konstantin Chegaev Italy 22 456 1.7× 426 2.1× 66 0.4× 180 1.4× 84 0.8× 70 1.4k
Simon Mysling Denmark 14 548 2.1× 94 0.5× 309 2.0× 174 1.4× 35 0.3× 14 1.1k

Countries citing papers authored by Youhong Hu

Since Specialization
Citations

This map shows the geographic impact of Youhong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youhong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youhong Hu more than expected).

Fields of papers citing papers by Youhong Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youhong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youhong Hu. The network helps show where Youhong Hu may publish in the future.

Co-authorship network of co-authors of Youhong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Youhong Hu. A scholar is included among the top collaborators of Youhong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youhong Hu. Youhong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jia, Xuedong, Tianyu Xu, Xuejun Yin, et al.. (2025). Investigating the status and influencing factors of professional identity formation among Chinese medical interns: a mixed methods study. BMC Medical Education. 25(1). 676–676. 1 indexed citations
2.
Jia, Xuedong, et al.. (2024). Development of a self-assessment tool to evaluate the readiness of pharmacy departments for internship training in China: a two-phase study. BMC Medical Education. 24(1). 1129–1129. 1 indexed citations
3.
Wang, Haoyu, et al.. (2024). Discovery of novel biaryl urea derivatives against IL-1β release with low toxicity based on NEK7 inhibitor. European Journal of Medicinal Chemistry. 283. 117125–117125.
4.
5.
Qin, Hui, Yunqi Wang, Linlin Wang, et al.. (2023). Discovery of selective NaV1.8 inhibitors based on 5-chloro-2-(4,4-difluoroazepan-1-yl)-6-methyl nicotinamide scaffold for the treatment of pain. European Journal of Medicinal Chemistry. 254. 115371–115371. 7 indexed citations
6.
Xia, Peng, Yinchun Ji, Yang Dai, et al.. (2021). The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation. Molecular Cancer Therapeutics. 20(11). 2198–2206. 9 indexed citations
7.
Che, Jinxin, Zhilong Wang, Xiaowu Dong, et al.. (2018). Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents. Royal Society Open Science. 5(7). 180176–180176. 20 indexed citations
8.
Che, Jinxin, et al.. (2018). Bicyclo[2.2.1]heptane containing N,N′-diarylsquaramide CXCR2 selective antagonists as anti-cancer metastasis agents. RSC Advances. 8(20). 11061–11069. 11 indexed citations
9.
Yu, Xueli, Gang Cheng, Lei Zhang, et al.. (2018). N-Phenylquinazolin-2-amine Yhhu4952 as a novel promotor for oligodendrocyte differentiation and myelination. Scientific Reports. 8(1). 14040–14040. 6 indexed citations
10.
Ma, Yiming, Yanmin Peng, Qionghua Zhu, et al.. (2016). Novel CHOP activator LGH00168 induces necroptosis in A549 human lung cancer cells via ROS-mediated ER stress and NF-κB inhibition. Acta Pharmacologica Sinica. 37(10). 1381–1390. 55 indexed citations
11.
12.
Han, Mei, Shan Li, Jing Ai, et al.. (2016). Discovery of 4-chloro-3-(5-(pyridin-3-yl)-1,2,4-oxadiazole-3-yl)benzamides as novel RET kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(23). 5679–5684. 10 indexed citations
13.
Yang, Liu, Peng Xia, Dong Lu, et al.. (2016). Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors. European Journal of Medicinal Chemistry. 126. 122–132. 11 indexed citations
14.
Ai, Jing, Shiyu Jin, Peng Xia, et al.. (2015). Enhancing the cellular anti-proliferation activity of pyridazinones as c-met inhibitors using docking analysis. European Journal of Medicinal Chemistry. 95. 302–312. 35 indexed citations
15.
Xu, Mingming, Steven H. Liang, Huaijiang Xiang, et al.. (2015). Discovery of a novel fluorescent probe for the sensitive detection of β-amyloid deposits. Biosensors and Bioelectronics. 75. 136–141. 27 indexed citations
16.
Ai, Jing, Yi Chen, Haotian Zhang, et al.. (2013). Yhhu3813 is a novel selective inhibitor of c-Met Kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells. Acta Pharmacologica Sinica. 35(1). 89–97. 15 indexed citations
17.
Liu, Yang, Jianping Fang, Haiyan Cai, et al.. (2012). Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors. Bioorganic & Medicinal Chemistry. 20(18). 5473–5482. 17 indexed citations
18.
Quan, Haitian, Chengying Xie, Yongping Xu, et al.. (2011). YHHU0895, a novel synthetic small-molecule microtubule-destabilizing agent, effectively overcomes P-glycoprotein-mediated tumor multidrug resistance. Cancer Letters. 314(1). 54–62. 12 indexed citations
19.
Zhou, Lijun, et al.. (2008). Synthesis and Biological Evaluation of Novel Isopropanolamine Derivatives as Non-peptide Human Immunodeficiency Virus Protease Inhibitors. Chemical and Pharmaceutical Bulletin. 56(8). 1147–1152. 4 indexed citations
20.
Hu, Youhong, Emmanuelle J. Meuillet, Margareta Berggren, Garth Powis, & Alan P. Kozikowski. (2001). 3-Deoxy-3-substituted-d-myo-inositol imidazolyl ether lipid phosphates and carbonate as inhibitors of the phosphatidylinositol 3-kinase pathway and cancer cell growth. Bioorganic & Medicinal Chemistry Letters. 11(2). 173–176. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuyan Li Breakdown of academic impact, for papers by Kondapa Naidu Bobba Breakdown of academic impact, for papers by Ruijuan Liu Breakdown of academic impact, for papers by Maria Weber Breakdown of academic impact, for papers by Xuepeng Dong Breakdown of academic impact, for papers by Jin Young Kim Breakdown of academic impact, for papers by Pat R. R. Langridge‐Smith Breakdown of academic impact, for papers by Konstantin Chegaev Breakdown of academic impact, for papers by Simon Mysling
Rankless by CCL
2026